JP2004532886A5 - - Google Patents

Download PDF

Info

Publication number
JP2004532886A5
JP2004532886A5 JP2003501845A JP2003501845A JP2004532886A5 JP 2004532886 A5 JP2004532886 A5 JP 2004532886A5 JP 2003501845 A JP2003501845 A JP 2003501845A JP 2003501845 A JP2003501845 A JP 2003501845A JP 2004532886 A5 JP2004532886 A5 JP 2004532886A5
Authority
JP
Japan
Prior art keywords
aminocarbonyl
ethoxycarbonyl
piperazin
carbonyl
quinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003501845A
Other languages
English (en)
Japanese (ja)
Other versions
JP4409936B2 (ja
JP2004532886A (ja
Filing date
Publication date
Priority claimed from US10/163,742 external-priority patent/US6861424B2/en
Application filed filed Critical
Publication of JP2004532886A publication Critical patent/JP2004532886A/ja
Publication of JP2004532886A5 publication Critical patent/JP2004532886A5/ja
Application granted granted Critical
Publication of JP4409936B2 publication Critical patent/JP4409936B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003501845A 2001-06-06 2002-06-06 血小板アデノシン二リン酸受容体アンタゴニスト Expired - Fee Related JP4409936B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29649801P 2001-06-06 2001-06-06
US10/163,742 US6861424B2 (en) 2001-06-06 2002-06-05 Platelet adenosine diphosphate receptor antagonists
PCT/US2002/017821 WO2002098856A2 (en) 2001-06-06 2002-06-06 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists

Publications (3)

Publication Number Publication Date
JP2004532886A JP2004532886A (ja) 2004-10-28
JP2004532886A5 true JP2004532886A5 (https=) 2009-08-20
JP4409936B2 JP4409936B2 (ja) 2010-02-03

Family

ID=26859907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003501845A Expired - Fee Related JP4409936B2 (ja) 2001-06-06 2002-06-06 血小板アデノシン二リン酸受容体アンタゴニスト

Country Status (5)

Country Link
US (4) US6861424B2 (https=)
EP (1) EP1412349A2 (https=)
JP (1) JP4409936B2 (https=)
AU (1) AU2002316191A1 (https=)
WO (1) WO2002098856A2 (https=)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
WO2003059884A1 (en) 2001-12-21 2003-07-24 X-Ceptor Therapeutics, Inc. Modulators of lxr
OA12970A (en) * 2002-12-11 2006-10-13 Schering Ag 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists.
WO2005009971A1 (ja) * 2003-07-24 2005-02-03 Astellas Pharma Inc. キノロン誘導体又はその塩
CN101031565B (zh) * 2004-09-29 2010-09-29 博尔托拉制药公司 取代的2h-1,3-苯并噁嗪-4(3h)-酮
TW200640877A (en) * 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives
WO2007016539A2 (en) * 2005-07-29 2007-02-08 Children's Hospital Medical Center Gtpase inhibitors and methods of use and crystal structure of rac-1 gtpase
JP4976394B2 (ja) * 2005-08-17 2012-07-18 シェーリング コーポレイション 新規な高親和性のキノリンベースのキナーゼリガンド
WO2007046075A1 (en) * 2005-10-21 2007-04-26 Actelion Pharmaceuticals Ltd Piperazine derivatives as antimalarial agents
US7615556B2 (en) * 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
TWI391378B (zh) 2006-03-16 2013-04-01 Astellas Pharma Inc 喹啉酮衍生物或其製藥學上可被容許之鹽
JP2009534310A (ja) * 2006-03-29 2009-09-24 武田薬品工業株式会社 レニン阻害剤
US20070254861A1 (en) * 2006-04-28 2007-11-01 Astellas Pharma Inc. Methods for the prevention and/or treatment of peripheral arterial disease
AR063258A1 (es) 2006-10-13 2009-01-14 Actelion Pharmaceuticals Ltd Derivados de 2-aminocarbonil-piridina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de trastornos vasculares oclusivos.
AR063518A1 (es) * 2006-10-25 2009-01-28 Actelion Pharmaceuticals Ltd Derivados 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades vasculares perifericas viscerales, hepaticas y renales, enfermedades cardiovasculares y enfermedades cerebrovasculares asociados con la agregacion de plaquetas, incluyendo trombosis
EP1967513A1 (en) * 2007-03-08 2008-09-10 Rheinische Friedrich-Wilhelms-Universität Bonn Novel P2Y12 receptor antagonists
KR20100015886A (ko) * 2007-04-23 2010-02-12 사노피-아벤티스 P2y12 길항제로서의 퀴놀린-카복스아미드 유도체
CN101679358B (zh) 2007-06-18 2013-10-30 塞诺菲-安万特股份有限公司 作为p2y12拮抗剂的吡咯衍生物
ES2388958T3 (es) * 2007-11-29 2012-10-22 Actelion Pharmaceuticals Ltd. Derivados de acido fosfonico y su uso como antagonista del receptor P2Y12
EP2238128B1 (en) * 2007-12-26 2012-08-22 Sanofi Heterocyclic pyrazole-carboxamides as p2y12 antagonists
AR071653A1 (es) * 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2-fenil-4-ciclopropil-pirimidina
AR071652A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2- fenil-piridina substituidos
US20130303477A1 (en) 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
US8759316B2 (en) 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US9427448B2 (en) 2009-11-11 2016-08-30 The Medicines Company Methods of treating, reducing the incidence of, and/or preventing ischemic events
US20120141468A1 (en) 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
WO2010075356A1 (en) * 2008-12-23 2010-07-01 Forest Laboratories Holdings Limited Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
KR101694563B1 (ko) 2009-04-08 2017-01-09 액테리온 파마슈티칼 리미티드 Adp 수용체 길항제로서 6-(3-아자-비시클로〔3.1.0〕헥스-3-일)-2-페닐-피리미딘
EP2421859B1 (en) 2009-04-22 2014-04-09 Actelion Pharmaceuticals Ltd. Thiazole derivatives and their use as p2y12 receptor antagonists
ES2470329T3 (es) 2009-08-28 2014-06-23 Daiichi Sankyo Company, Limited Derivado del ácido 3-(biariloxi) priopi�nico
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
PT2498731T (pt) 2009-11-11 2020-02-21 Chiesi Farm Spa Métodos de tratamento ou prevenção de uma trombose de endoprótese
JP2013512246A (ja) 2009-11-25 2013-04-11 メルク・シャープ・アンド・ドーム・コーポレーション ウイルス疾患治療に有用な縮合型三環式化合物およびその誘導体
US20130156731A1 (en) 2009-12-22 2013-06-20 Kevin X. Chen Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas
US8889688B2 (en) 2010-01-05 2014-11-18 Actelion Pharmaceuticals Ltd. Piperazines as antimalarial agents
EA201290882A1 (ru) 2010-03-09 2013-04-30 Мерк Шарп Энд Домэ Корп. Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
US20140378416A1 (en) 2011-09-14 2014-12-25 Michael P. Dwyer Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
GB201218084D0 (en) * 2012-10-09 2012-11-21 Univ Aston Novel compounds and methods for use in medicine
CA2901920A1 (en) 2013-03-15 2014-09-18 Actelion Pharmaceuticals Ltd Novel acrylamide derivatives as antimalarial agents
HUE057772T2 (hu) 2016-09-22 2022-06-28 Idorsia Pharmaceuticals Ltd Kristályos formák
US11179390B2 (en) 2017-03-15 2021-11-23 Idorsia Pharmaceuticals Ltd Subcutaneous administration of a P2Y12 receptor antagonist
US11260071B2 (en) 2017-06-23 2022-03-01 Chiesi Farmaceutici S.P.A. Method of preventing of systemic-to-pulmonary-artery shunt thrombosis
WO2020085504A1 (ja) 2018-10-26 2020-04-30 大鵬薬品工業株式会社 光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法
EP4031542B1 (en) * 2019-09-18 2025-10-15 Merck Sharp & Dohme LLC Small molecule inhibitors of kras g12c mutant
CN114867726B (zh) 2019-10-28 2023-11-28 默沙东有限责任公司 Kras g12c突变体的小分子抑制剂
US12479834B2 (en) 2019-11-29 2025-11-25 Taiho Pharmaceutical Co., Ltd. Phenol compound or salt thereof
US11945790B2 (en) * 2020-12-22 2024-04-02 Immunomolecular Therapeutics, Inc. Compounds and methods for treating autoimmune disorders by targeting HLA-DQ2
WO2025085748A1 (en) 2023-10-20 2025-04-24 Merck Sharp & Dohme Llc Small molecule inhibitors of kras proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1334705A (en) 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
US4258192A (en) 1977-12-16 1981-03-24 Mitsubishi Chemical Industries Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US5346907A (en) 1988-04-05 1994-09-13 Abbott Laboratories Amino acid analog CCK antagonists
CA2073776A1 (en) 1990-11-15 1992-05-16 Joerg Stuerzebecher Meta-substituted phenyl alanine derivatives
JPH07509731A (ja) 1993-02-10 1995-10-26 ペンタファルム アクチェンゲゼルシャフト トロンビン阻害剤としての置換されたフェニルアラニン誘導体のピペラジド
KR0173034B1 (ko) 1995-04-28 1999-03-30 성재갑 선택적 트롬빈 억제제
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
DE60022508T2 (de) * 1999-06-14 2006-06-08 Eli Lilly And Co., Indianapolis Inhibitoren von serin proteasen

Similar Documents

Publication Publication Date Title
JP2004532886A5 (https=)
US11192868B2 (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
US6995156B2 (en) Platelet adenosine diphosphate receptor antagonists
JP4327249B2 (ja) 抗ヘルペスウイルス性を有するフェニルチアゾール誘導体
JP2004513063A5 (https=)
US7687504B2 (en) Pyrrolidine compounds
JP2002533434A5 (https=)
SK171399A3 (en) Piperazine derivatives and their use as anti-inflammatory agents
CA2507657A1 (en) 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
US20060276524A1 (en) 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12
ES2436772T3 (es) Derivados de piperidina como inhibidores del virus del papiloma humano
US8466161B2 (en) Hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
CN1324353A (zh) 新的脒衍生物,其制备方法,其作为药物的用途以及含有该化合物的药物组合物
JP2008524244A5 (https=)
JP2005504093A5 (https=)
CN102596921B (zh) 新化合物
ES2328929T3 (es) Dihidroquinazolinas 2-sustituidas.
US20080119471A1 (en) Piperazine urea derivatives for the treatment of endometriosis
BR9815967A (pt) Processo para a preparação de um derivado de amino-5-cloro de 3(2h)-piridazinona-4-substituìdo
CN100451004C (zh) 嘧啶衍生物
ME01506B (me) MODULATORI INDOLAMIN 2,3-DIOKSIGENAZE l POSTUPCI UPOTREBE ISTIH
HK1117392B (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
HK1182381B (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same